Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00117962
What this trial is testing

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 109
Testing effectiveness (Phase 2)Study completedNCT00006483
What this trial is testing

Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung

Who this might be right for
Kidney CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Early research (Phase 1)Ended earlyNCT06974734
What this trial is testing

A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

Who this might be right for
Carcinoma, Non Small Cell LungCarcinoma, Pancreatic DuctalMalignant Melanoma+1 more
Pfizer 8
Early research (Phase 1)Ended earlyNCT02376699
What this trial is testing

Safety Study of SEA-CD40 in Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Squamous CellHodgkin Disease+17 more
Seagen Inc. 159
Testing effectiveness (Phase 2)Study completedNCT02979821
What this trial is testing

Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001)

Who this might be right for
HER2 Gene MutationAdenocarcinoma Lung Stage IV
Korean Association for the Study of Targeted Therapy 6
Not applicableLooking for participantsNCT05665504
What this trial is testing

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Who this might be right for
Lung; NodeAdenocarcinoma of Lung
H. Lee Moffitt Cancer Center and Research Institute 250
Early research (Phase 1)Looking for participantsNCT07090499
What this trial is testing

Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more
Pfizer 540
Not applicableActive Not RecruitingNCT05982574
What this trial is testing

Tumor Microenvironment

Who this might be right for
Lung Adenocarcinoma
University Hospital Heidelberg 300
Testing effectiveness (Phase 2)Study completedNCT02264210
What this trial is testing

Icotinib for Completed Resected IB NSCLC With EGFR Mutation

Who this might be right for
Lung NeoplasmsSquamous Cell Lung CancerAdenocarcinoma of the Lung+4 more
Sun Yat-sen University 128
Early research (Phase 1)WithdrawnNCT01741597
What this trial is testing

Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasLiver Metastases+5 more
City of Hope Medical Center
Not applicableStudy completedNCT06164574
What this trial is testing

Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers

Who this might be right for
Lung Cancer
Haiquan Chen 627
Testing effectiveness (Phase 2)Ended earlyNCT04161391
What this trial is testing

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Who this might be right for
Non Small Cell Lung CancerMedullary Thyroid CancerRET Gene Mutation+2 more
Turning Point Therapeutics, Inc. 41
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Early research (Phase 1)Looking for participantsNCT04999761
What this trial is testing

AB122 Platform Study

Who this might be right for
Advanced or Metastatic Solid TumorPancreatic Ductal AdenocarcinomaColorectal Cancer+6 more
Taiho Pharmaceutical Co., Ltd. 917
Testing effectiveness (Phase 2)WithdrawnNCT05566223
What this trial is testing

CISH Inactivated TILs in the Treatment of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungMetastatic Non Small Cell Lung CancerStage IV Non-small Cell Lung Cancer+3 more
Intima Bioscience, Inc.
Large-scale testing (Phase 3)Study completedNCT00002550
What this trial is testing

Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 429
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT07145255
What this trial is testing

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Who this might be right for
Prostate Cancer Castration-resistant Prostate CancerBreast CancerColo-rectal Cancer+2 more
MBrace Therapeutics 150
Not applicableLooking for participantsNCT07636148
What this trial is testing

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Who this might be right for
Liver Cancer (Primary and Metastatic)Lung Cancer (Diagnosis)Bone Cancer Metastatic+10 more
Mark C Burgmans, MD PhD 2,000
Next Page